3 Boomerang Capital I
Managed by 3 Boomerang Capital
Overview
3 Boomerang Capital I is the manager’s inaugural fund, focused on lower middle-market healthcare businesses. The fund follows a sector-led approach spanning biopharma outsourcing, medical device and diagnostic manufacturing, healthcare information technology and tech-enabled services, and alternate-site care. The fund invests in founder- and entrepreneur-owned businesses and corporate carve-outs, using control or minority structures to support expansion, acquisitions, recapitalizations and management buyouts.
3 Boomerang Capital is a healthcare-focused private equity firm that partners with lower middle-market companies in North America and Western Europe. The firm is led by co-founders Adam Dolder and Adam Elberg and brings investing, operating and healthcare-sector experience to its portfolio companies. The manager focuses on biopharma outsourcing, medical device and diagnostic manufacturing, information technology and tech-enabled services, and alternate-site care. Its approach emphasizes hands-on ownership, operational support and collaboration with management teams.
Selected investments
- ABS Bio — The fund invested in ABS Bio, formerly Analytical Biological Services, a provider of biospecimen procurement and analysis, cell culture, biostorage and related research services for biopharma customers.
- Bio-Response Solutions — The fund invested in Bio-Response Solutions, which designs and builds alkaline hydrolysis equipment and specialized sterilization systems.
Acquire an interest in 3 Boomerang Capital I
You might be able to acquire a position in 3 Boomerang Capital I. Sign up to explore available positions.
Gauge buyer interest for 3 Boomerang Capital I
Sign up here to anonymously gauge interest in your 3 Boomerang Capital I position.
Do you manage this fund? Get in touch to edit the text here.